Skip to content
Screener

Baxter International BAX Healthcare Systems & Technologies — Selling, general and administrative expenses

Other segment segments

Medical Products & Therapies
$290M+1.4%
Pharmaceuticals
$102M-1.0%

Similar metrics at other companies

Huron Consulting Group logo
HURNHealthcare — Selling, general and administrative expenses
$10.09M-7.0%
Honeywell International logo
HONAerospace Technologies — Selling, general and administrative expenses
$204M+12.7%
Lear Corporation logo
LEASeating — Selling, general and administrative expenses
$97.9M+14.5%
Phinia logo
PHINFuel Systems — Selling, general and administrative expenses
$21M+23.5%
Lear Corporation logo
LEAE-Systems — Selling, general and administrative expenses
$35.9M+1.1%
BorgWarner logo
BWAPowerDrive Systems — Selling, general and administrative expenses
$82M-11.8%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Three Months Ended March 31, 2026 / Medical Products & TherapiesThree Months Ended March 31, 2026 / Healthcare Systems & TechnologiesThree Months Ended March 31, 2026 / PharmaceuticalsThree Months Ended March 31, 2025 / Medical Products & TherapiesThree Months Ended March 31, 2025 / Healthcare Systems & TechnologiesThree Months Ended March 31, 2025 / Pharmaceuticals
Net sales$1,285$705$621$1,262$704$581
Cost of sales781390458694356396
Selling, general and administrative expenses290209102286217103
Research and development expenses544922594526
Other segment items(26)(9)(7)(21)(7)(7)
Segment operating income$186$66$46$244$93$63

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's healthcare systems & technologies — selling, general and administrative expenses?
Baxter International (BAX) reported healthcare systems & technologies — selling, general and administrative expenses of $209M in Q1 2026.
How has Baxter International's healthcare systems & technologies — selling, general and administrative expenses changed year-over-year?
Baxter International's healthcare systems & technologies — selling, general and administrative expenses decreased by 3.7% year-over-year, from $217M to $209M.
What is the long-term trend for Baxter International's healthcare systems & technologies — selling, general and administrative expenses?
Over 3 years (2022 to 2025), Baxter International's healthcare systems & technologies — selling, general and administrative expenses has grown at a 1.8% compound annual growth rate (CAGR), from $827M to $873M.
What does healthcare systems & technologies — selling, general and administrative expenses mean?
Covers the operating costs not directly tied to production, including sales force commissions, marketing, administrative salaries, and general corporate overhead allocated to the segment. It reflects the cost of supporting the segment's commercial infrastructure.

Ask your AI about Baxter International's healthcare systems & technologies — selling, general and administrative expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude